Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Cincinnati at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This phase II trial studies how well CBX-12 works in treating patients with microsatellite stable colorectal cancer that has spread to other parts of the body (metastatic) and is no longer responding to chemotherapy treatment (chemotherapy-refractory). The usual approach to treating colorectal cancer includes treatment with surgery, radiation, or Food and Drug Administration (FDA)-approved drugs such as trifluridine-tipiracil, bevacizumab, regorafenib, or fruquintinib. However, most metastatic c
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this colorectal cancer clinical trial in Cincinnati, OH
If you're searching for colorectal cancer treatment options in Cincinnati, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.